Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies.

Dechant, Michael

Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies. [electronic resource] - Cancer research Jul 2008 - 4998-5003 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1538-7445

10.1158/0008-5472.CAN-07-6226 doi


Antibodies--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antibody-Dependent Cell Cytotoxicity--physiology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Caco-2 Cells
Cell Death--drug effects
Cetuximab
Complement System Proteins--physiology
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Epitope Mapping
ErbB Receptors--immunology
Humans
Immunoglobulin A--administration & dosage
Immunoglobulin Fab Fragments--administration & dosage
Models, Biological
Neoplasms--drug therapy
Panitumumab
Tumor Cells, Cultured